Avery, Billie Jean

359 S.W.3d 230, 2012 Tex. Crim. App. LEXIS 360, 2012 WL 631876
CourtCourt of Criminal Appeals of Texas
DecidedFebruary 29, 2012
DocketPD-0864-11
StatusPublished
Cited by27 cases

This text of 359 S.W.3d 230 (Avery, Billie Jean) is published on Counsel Stack Legal Research, covering Court of Criminal Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Avery, Billie Jean, 359 S.W.3d 230, 2012 Tex. Crim. App. LEXIS 360, 2012 WL 631876 (Tex. 2012).

Opinion

WOMACK, J.,

delivered the opinion of the unanimous Court.

The appellant was convicted of attempting to obtain a controlled substance “through use of a fraudulent prescription form.” 1 The Thirteenth Court of Appeals acquitted the appellant because it found no evidence that she used a fraudulent prescription form. 2 We shall affirm the Court of Appeals’s judgment, though we disagree with some of the Court’s reasoning and interpretation of the record.

I. Trial

The evidence showed that on January 15, 2009, the appellant complained to her doctor of knee and back pain and received from him a prescription for forty 2.5 milligram Lortab pills. Before she dropped off the prescription at the pharmacy, the appellant attempted to scribble out the “2.5” and make it look like “7.5.” The on-duty pharmacist became suspicious and called the office of the appellant’s doctor, where a nurse said that the prescription should have been for 2.5 milligram pills. The pharmacist then called store security, who contacted police.

After the State rested, the appellant moved for a directed verdict of acquittal. She argued that, while there was evidence *233 that she committed forgery, which might allow a conviction under Health & Safety Code Section 481.129(a)(5)(A), there was no evidence that she used a fraudulent prescription form as alleged in the indictment, which used the statutory manner and means listed in Section 481.129(a)(5)(B): 3

The testimony is that the prescription form is not fraudulent. It is the prescription form of the doctor. What the testimony has been is that the prescription, itself, that the doctor wrote on his form was altered .... There’s no evidence that [the appellant] committed this fraud by using a fraudulent prescription form ....

The State responded that by altering an otherwise legitimate prescription, the appellant had created a fraudulent prescription form. The trial court denied the appellant’s motion. The jury found the appellant guilty and assessed her punishment of 25 years’ confinement and a $1,500 fine.

II. Direct Appeal

Before the Thirteenth Court of Appeals, the appellant argued that a “prescription form” consisted of “only two elements: (1) the actual paper a practitioner uses to record a prescription; and (2) that paper’s preprinted markings. In order for a prescription form to be fraudulent, one of those elements must be directly affected by a fraudulent act.” Because her fraudulent act affected only the prescription information handwritten by the doctor, the prescription form itself was not fraudulent, and she was entitled to an acquittal.

The State countered by arguing that under Health & Safety Code Section 481.075 — which outlines the “Official Prescription Program” that prescribers must follow in order to prescribe Schedule II controlled substances 4 — the elements of an “official prescription form” include the controlled substance prescribed as well as the quantity of that controlled substance. 5 Because the prescriber’s written words were part of the “official prescription form,” according to the State, when the appellant altered those written words she turned the entire document into a “fraudulent prescription form.”

The Court of Appeals’s majority accepted neither party’s argument in full. It agreed with the State that the prescription form was “essentially” an “official prescription form.” 6 Instead of addressing whether the appellant’s actions fit the definition of using a “fraudulent prescription form,” however, the Court of Appeals saw its job as determining whether the appellant’s actions were “more” like the “misrepresentation, fraud, forgery, deception, or subterfuge” barred in Section 481.129(a)(5)(A), or like the “use of a fraudulent prescription form,” barred in Section 481.129(a)(5)(B). 7 Because it determined that subsections (A) and (B) were *234 mutually exclusive — ie., an action might fall under (A) or it might fall under (B), but it could not fall under both — and because it determined that the appellant’s actions more closely resembled “forgery” than “use of a fraudulent prescription form,” the Court of Appeals vacated the trial court’s judgment and entered a verdict of acquittal.

III. Factual Matters

We granted the State’s petition for discretionary review to determine whether the Court of Appeals correctly interpreted the phrase “fraudulent prescription form.” Before we can address that matter, however, we need to address several factual matters in the Court of Appeals’s opinion.

A. Lortab

The first sentence of the Court of Appeals’s opinion was:

Appellant, Billie Jean Avery, was charged by indictment with obtaining an increased quantity of a Schedule II controlled substance through the use of a fraudulent prescription form, a second-degree felony. 8

We do not so read the record. The indictment alleged that the appellant attempted to use a fraudulent prescription form “to obtain a controlled substance, namely, Lor-tab .... ” without specifying which Schedule Lortab is on. The Court of Appeals cited to two cases stating that hydroco-done, one of the ingredients in Lortab, is a Schedule II controlled substance. 9 It also cited to a website that described Lortab as a combination of hydrocodone and acetaminophen. 10

A different page on that same website, however, states that certain mixtures that include hydrocodone are Schedule III controlled substances. 11 The Schedules published by the Commissioner of Public Health confirm that hydrocodone is a Schedule II controlled substance, but certain mixtures that include hydrocodone are Schedule III controlled substances. 12

Although the record contains no information regarding the specific hydrocodone mixture contained in the Lortab pills the appellant sought, it does contain the pharmacist’s testimony that Lortab was a Schedule III controlled substance. There was no contradictory testimony or arguments by the parties that she was mistaken.

We think that the record must be read to say that the prescription was for a Schedule III controlled substance.

B. “Official Prescription Form”

That reading of the record means that the Court of Appeals was incorrect to have looked to Health & Safety Code Section 481.075 as a source for determining the composite parts of a “prescription *235

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Peo in Interest of Hetzel
Colorado Court of Appeals, 2025
Dillion Alan Neill v. THE STATE OF TEXAS
Court of Appeals of Texas, 2024
Ex Parte Todd T. Bornhop
Court of Appeals of Texas, 2022
William Ellis Douglass v. the State of Texas
Court of Appeals of Texas, 2022
State v. Culberson
2021 Ohio 2214 (Ohio Court of Appeals, 2021)
Adrian Cardona Velasquez v. State
Court of Appeals of Texas, 2018
Jones, David Deron
Court of Criminal Appeals of Texas, 2017
Brenda Guadalupe Trevino v. State
512 S.W.3d 587 (Court of Appeals of Texas, 2017)
Edwards v. State
487 S.W.3d 330 (Court of Appeals of Texas, 2016)
Rundles v. State
486 S.W.3d 730 (Court of Appeals of Texas, 2016)
Sneed, Robert
Court of Criminal Appeals of Texas, 2015
Lewis, Darren D.
Court of Criminal Appeals of Texas, 2015
Ricks, Cedric Allen
Texas Supreme Court, 2015
Anthony, John Dennis Clayton
Court of Appeals of Texas, 2015
Liverman, Roger
Court of Appeals of Texas, 2015
Ex Parte Ray Louis Johnson, Jr.
Court of Appeals of Texas, 2015
Holloway, Joshua J.
Court of Appeals of Texas, 2015
Craig Lee Smith v. State
Court of Appeals of Texas, 2015
Ariel Medina v. State
411 S.W.3d 15 (Court of Appeals of Texas, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
359 S.W.3d 230, 2012 Tex. Crim. App. LEXIS 360, 2012 WL 631876, Counsel Stack Legal Research, https://law.counselstack.com/opinion/avery-billie-jean-texcrimapp-2012.